Investor Relations

Corporate Profile

Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome.

Data Provided by Refinitiv. Minimum 15 minutes delayed.